Home Page | Photos | Video | Forum | Most Popular | Special Reports | Biz China Weekly
Make Us Your Home Page
Most Searched: G20  CPC  South China Sea  Belt and Road Initiative  AIIB  

Britain's pancreatic cancer research project gets major funding

Source: Xinhua   2017-03-25 02:26:38

LONDON, March 24 (Xinhua) -- Cancer Research UK announced Friday that it would invest a substantial amount of money in a research project that seeks to find new treatments for pancreatic cancer.

The investment of 10 million pounds (around 12.5 million U.S. dollars) will support the Precision Panc project, which will be carried out by researchers across Britain.

As part of the project, the project team plans to conduct three clinical trials and recruit 658 patients in Britain. More trials will be carried out in the future if everything goes smoothly.

The investment will support two of the three clinical trials, preclinical work, assay development, biomarker work and the huge amount of molecular sequencing.

"Because the disease is so aggressive, patients may receive no treatment at all, or if they are given an option it will be for just one line of treatment, so it's essential that the most suitable treatment is identified quickly," said Professor Andrew Biankin from the University of Glasgow, who has pioneered the project.

"It's important we offer all patients the opportunity to be part of research alongside their standard care," Biankin added.

Editor: Mu Xuequan
Related News
           
Photos  >>
Video  >>
  Special Reports  >>
Xinhuanet

Britain's pancreatic cancer research project gets major funding

Source: Xinhua 2017-03-25 02:26:38
[Editor: huaxia]

LONDON, March 24 (Xinhua) -- Cancer Research UK announced Friday that it would invest a substantial amount of money in a research project that seeks to find new treatments for pancreatic cancer.

The investment of 10 million pounds (around 12.5 million U.S. dollars) will support the Precision Panc project, which will be carried out by researchers across Britain.

As part of the project, the project team plans to conduct three clinical trials and recruit 658 patients in Britain. More trials will be carried out in the future if everything goes smoothly.

The investment will support two of the three clinical trials, preclinical work, assay development, biomarker work and the huge amount of molecular sequencing.

"Because the disease is so aggressive, patients may receive no treatment at all, or if they are given an option it will be for just one line of treatment, so it's essential that the most suitable treatment is identified quickly," said Professor Andrew Biankin from the University of Glasgow, who has pioneered the project.

"It's important we offer all patients the opportunity to be part of research alongside their standard care," Biankin added.

[Editor: huaxia]
010020070750000000000000011105091361560031